Raymond James Financial’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.95M Sell
254,393
-7,263
-3% -$270K ﹤0.01% 2164
2026
Q1
$10.5M Buy
261,656
+7,950
+3% +$376K ﹤0.01% 1980
2025
Q4
$11.4M Sell
253,706
-8,358
-3% -$387K ﹤0.01% 1850
2025
Q3
$11.7M Buy
262,064
+72,674
+38% +$3.48M ﹤0.01% 1793
2025
Q2
$9.1M Sell
189,390
-32,924
-15% -$1.43M ﹤0.01% 1943
2025
Q1
$8.93M Sell
222,314
-19,102
-8% -$804K ﹤0.01% 1897
2024
Q4
$11.1M Buy
+241,416
New +$10.8M ﹤0.01% 1776

Other funds holding QGEN

Raymond James Financial's QGEN Position: Q2 2026 in Review

Raymond James Financial reduced its Qiagen (QGEN) stake by 2.8% in Q2 2026, selling an estimated $270K and leaving 254,393 shares worth $9.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

Raymond James Financial first reported a position in QGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.7M in Q3 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Raymond James Financial held 254,393 shares of Qiagen worth $9.95M as of Q2 2026.
  • Raymond James Financial sold 7,263 Qiagen shares in Q2 2026, an estimated $270K.
  • Qiagen made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2164 holding.
  • Raymond James Financial first reported a position in Qiagen in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Qiagen position peaked at $11.7M in Q3 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.